Description

Capecitabin Amaxa (capecitabine) Coated Tablets 500 mg. №120

Ingredients

Active ingredient: Capecitabine 500 mg.
Other ingredients: Microcrystalline cellulose, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, and purified talc.

Dosage

Recommended dosage: The usual dose is 1250 mg/m² administered orally twice daily (morning and evening) for 2 weeks followed by a 1-week rest period.

Indications

Capecitabin Amaxa tablets are indicated for the treatment of metastatic breast cancer and colorectal cancer.

Contraindications

Do not use Capecitabin Amaxa tablets if you have a known hypersensitivity to capecitabine or any of the excipients in the formulation.

Directions

Take Capecitabin Amaxa tablets exactly as prescribed by your healthcare provider. Swallow the tablets whole with water within 30 minutes after a meal.

Scientific Evidence

Capecitabine, the active ingredient in Capecitabin Amaxa tablets, is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body. 5-FU is an antimetabolite that interferes with DNA synthesis and cell division, leading to cell death in rapidly dividing cancer cells.

Additional Information

In clinical trials, Capecitabine has shown efficacy in the treatment of metastatic breast cancer and colorectal cancer. Studies have demonstrated its comparable effectiveness to intravenous 5-FU with a more favorable safety profile and convenient oral administration.

Capecitabin Amaxa tablets offer a convenient and effective treatment option for patients with metastatic breast cancer and colorectal cancer. By providing a targeted approach to cancer treatment, these tablets help to inhibit the growth and spread of cancer cells.

Research studies have highlighted the importance of Capecitabine in improving overall survival rates and quality of life in patients with advanced cancer. Its mechanism of action and tolerability make it a valuable addition to cancer treatment regimens.